Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy

Amanda M. Lynn, Siddharth Singh, Stephen E. Congly, Disha Khemani, David H. Johnson, Russell H. Wiesner, Patrick S. Kamath, James C. Andrews, Michael D. Leise – 11 March 2016 – Treatment options for refractory hepatic encephalopathy (HE) are limited. Patients who fail medical management may harbor large portosystemic shunts (PSSs) which are possible therapeutic targets. This study aims to describe patient selection, effectiveness, and safety of percutaneous PSS embolization in those with medically refractory HE.

Graft selection strategy in adult‐to‐adult living donor liver transplantation: When both hemiliver grafts meet volumetric criteria

Takeshi Kurihara, Tomoharu Yoshizumi, Yoshihiro Yoshida, Toru Ikegami, Shinji Itoh, Norifumi Harimoto, Mizuki Ninomiya, Hideaki Uchiyama, Hirohisa Okabe, Koichi Kimura, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara – 8 March 2016 – To ensure donor safety in living donor liver transplantation (LDLT), the left and caudate lobe (LL) is the preferred graft choice. However, patient prognosis may still be poor even if graft volume (GV) selection criteria are met. Our aim was to evaluate the effects of right lobe (RL) donation when the LL graft selection criteria are met.

The new liver allocation score for transplantation is validated and improved transplant survival benefit in Germany but not in the United Kingdom

Harald Schrem, Moritz Focken, Bridget Gunson, Benedikt Reichert, Darius Mirza, Hans‐Heinrich Kreipe, Desley Neil, Alexander Kaltenborn, Alon Goldis, Christian Krauth, Keith Roberts, Thomas Becker, Jürgen Klempnauer, James Neuberger – 7 March 2016 – Prognostic models for the prediction of 90‐day mortality after transplantation with pretransplant donor and recipient variables are needed to calculate transplant benefit.

Subscribe to